GLOBUS MEDICAL INC - A (GMED) Stock Analyst Ratings
USA - NYSE:GMED - US3795772082 - Common Stock
84.46 USD
-0.25 (-0.3%)
ChartMill assigns a Buy % Consensus number of 75% to GMED. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 81.91. This target is -3.02% below the current price.
GMED was analyzed by 21 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about GMED.
In the previous month the buy percentage consensus was at a similar level.
GMED was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-10 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-07 | Truist Securities | Upgrade | Hold -> Buy |
| 2025-11-07 | B of A Securities | Upgrade | Neutral -> Buy |
| 2025-10-28 | Stifel | Reiterate | Hold |
| 2025-08-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-07-22 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-07-21 | Needham | Reiterate | Hold -> Hold |
| 2025-07-15 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-27 | BTIG | Downgrade | Buy -> Neutral |
| 2025-05-27 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2025-05-12 | Truist Securities | Maintains | Hold -> Hold |
| 2025-05-09 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-04-11 | Truist Securities | Maintains | Hold -> Hold |
| 2025-03-18 | Needham | Reiterate | Hold -> Hold |
| 2025-03-18 | Truist Securities | Maintains | Hold -> Hold |
| 2025-02-24 | Citizens Capital Markets | Reiterate | Market Perform -> Market Perform |
| 2025-02-24 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-21 | Needham | Reiterate | Hold -> Hold |
| 2025-02-21 | Stifel | Maintains | Buy -> Buy |
| 2025-02-21 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-02-06 | Needham | Reiterate | Hold -> Hold |
| 2025-01-10 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-01-09 | Needham | Reiterate | Hold -> Hold |
| 2025-01-09 | B of A Securities | Upgrade | Underperform -> Neutral |
| 2024-12-18 | Truist Securities | Maintains | Hold -> Hold |
| 2024-12-17 | Roth MKM | Maintains | Buy -> Buy |
| 2024-12-12 | BTIG | Maintains | Buy -> Buy |
| 2024-12-11 | Wells Fargo | Maintains | Overweight -> Overweight |
GLOBUS MEDICAL INC - A / GMED FAQ
What is the average price target for GLOBUS MEDICAL INC - A (GMED) stock?
21 analysts have analysed GMED and the average price target is 81.91 USD. This implies a price decrease of -3.02% is expected in the next year compared to the current price of 84.46.
Can you provide the consensus rating for GLOBUS MEDICAL INC - A stock?
The consensus rating for GLOBUS MEDICAL INC - A (GMED) is 75.2381 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover GLOBUS MEDICAL INC - A (GMED) stock?
The number of analysts covering GLOBUS MEDICAL INC - A (GMED) is 21.